Skip to main content

MFI for Particle Characterization of Biopharmaceuticals Today

Whitepapers Summary

Thank you for your interest in MFI for Particle Characterization of Biopharmaceuticals Today. Please download your Whitepapers below.


Regulatory agencies currently require sub-visible particles to be well characterized in biopharmaceutical formulations due to concerns about undesired side effects and reduced efficacy. Because of this, sub-visible particle characterization is a key step in evaluating the quality attributes of complex biopharmaceuticals. Read this white paper to see how MFI is used for particle characterize in the biopharmaceutical industry. 

Default Literature Icon